← Leaderboards
Allison Brashear
State University Of New York At Buffalo
$9,106,797
Attributed
$9,271,796
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $831.9K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,271,796 · 3
By mechanism
R01$8,946,798 · 1
U24$309,998 · 1
R13$15,000 · 1
Top collaborators
- Pamela W. Duncan1 shared
- Kevin C Ess1 shared
- Alfred L George1 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Joshua Henry Gordon$170,958
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationAtp1a3 GeneProteinsGenesDystonia 12PhenotypeNeuronsMotorSymptomsDiagnosisCellsFunctional DisorderPublishingBrainGenotypeVariantBiochemicalEvaluationNeurologicNa(+)-K(+)-Exchanging AtpaseReportingParkinsonian DisordersDisabling DiseaseDystonia
Grant awards (21)
Clinical, Genetic, and Cellular Consequences of Mutations In NA,K-ATPase ATP1A3$635,579
R01 · FY2025 · NS · contact PI
Supplement to Clinical, Genetic, and Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$67,312
R01 · FY2025 · NS · contact PI
CLINICAL, GENETIC, AND CELLULAR CONSEQUENCES OF MUTATIONS IN NA,K-ATPASE ATP1A3$603,953
R01 · FY2024 · NS · contact PI
CLINICAL, GENETIC, AND CELLULAR CONSEQUENCES OF MUTATIONS IN NA,K-ATPASE ATP1A3$631,932
R01 · FY2023 · NS · contact PI
CLINICAL, GENETIC, AND CELLULAR CONSEQUENCES OF MUTATIONS IN NA,K-ATPASE ATP1A3$706,599
R01 · FY2022 · NS · contact PI
CLINICAL, GENETIC, AND CELLULAR CONSEQUENCES OF MUTATIONS IN NA,K-ATPASE ATP1A3$717,112
R01 · FY2021 · NS · contact PI
CLINICAL, GENETIC, AND CELLULAR CONSEQUENCES OF MUTATIONS IN NA,K-ATPASE ATP1A3$536,786
R01 · FY2019 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$20,698
R01 · FY2019 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$506,910
R01 · FY2018 · NS · contact PI
Wake Forest NeuroNext Clinical Site (WAKENN)$309,998
U24 · FY2018 · NS · contact PI
7th Symposium on ATP1A3 function in health and disease$15,000
R13 · FY2018 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$579,619
R01 · FY2017 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$593,745
R01 · FY2016 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$677,295
R01 · FY2015 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$1,400
R01 · FY2014 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$618,971
R01 · FY2011 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$620,393
R01 · FY2010 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$35,520
R01 · FY2010 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$636,369
R01 · FY2009 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$95,000
R01 · FY2009 · NS · contact PI
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3$661,605
R01 · FY2008 · NS · contact PI